Breaking News
August 15, 2018 - Cardiac Profiles Up With Exercise, Less Sitting in Early Old Age
August 15, 2018 - Precision medicine offers a glimmer of hope for Alzheimer’s disease
August 15, 2018 - Immunovia’s new blood-based testing platform accurately detects non-small cell lung cancer
August 15, 2018 - New method provides a ‘big picture’ of genetic influences on traits and diseases
August 15, 2018 - Early Onset Type 1 Diabetes Linked to Heart Disease, Shorter Life
August 14, 2018 - SMURF1 provides targeted approach to preventing cocaine addiction relapse
August 14, 2018 - Genetic testing pushed for hereditary high cholesterol disease
August 14, 2018 - Researchers discover new genes involved in Alzheimer’s Disease
August 14, 2018 - Medicare to overhaul ACOs but critics fear fewer participants
August 14, 2018 - Adolescent health projects receive meager percentage of global funding, study finds
August 14, 2018 - University Hospitals Seidman Cancer Center launches new CAR-T therapy trial
August 14, 2018 - In the addiction battle, is forced rehab the solution?
August 14, 2018 - Busting myths about milk – Scope
August 14, 2018 - Platelet-rich plasma does not enhance cartilage formation capabilities of stem cells
August 14, 2018 - Wearable devices and ‘mhealth’ technology emerge as promising tools for better health
August 14, 2018 - Clinical study suggests new treatment direction for head and neck cancer in heavy smokers
August 14, 2018 - Phase 2 Clinical Data Published Showing Summit’s Ridinilazole Preserved Gut Microbiome of Patients with CDI
August 14, 2018 - Cardiac progenitor cells undergo a cell fate switch to build coronary arteries
August 14, 2018 - Study identifies potential guidance to treat gastric cancer patients
August 14, 2018 - Revealed: The molecular mechanism underlying hypertrophic cardiomyopathy, or “workaholic heart”
August 14, 2018 - Diabetes epidemic in Guatemala driven by aging, not obesity
August 14, 2018 - New technology shows potential to streamline the analysis of proteins
August 14, 2018 - Rethinking the stroke rule ‘time is brain’
August 14, 2018 - Incidence of coronary artery compression in children may be more common than previously thought
August 14, 2018 - Study helps to better understand disease caused by Alpha-1 antitrypsin deficiency
August 14, 2018 - AI platform identifies acute neurological illnesses faster than human diagnosis
August 14, 2018 - American College of Rheumatology receives grants to support development of lupus clinical trials
August 14, 2018 - New study explains why women get more migraines than men
August 14, 2018 - American Heart Association Urges Screen Time Limits for Youth
August 14, 2018 - Brief interventions during routine care reduce alcohol use among men with HIV
August 14, 2018 - New genome analysis could identify people at higher risk of common deadly diseases
August 14, 2018 - NIH grant for Mount Sinai to study use of inhaled corticosteroids for treatment of sickle cell disease
August 14, 2018 - Daicel supplies free nanodiamond samples to international researchers
August 14, 2018 - Switching anti-psychotic drugs in first-episode schizophrenia patients does not improve clinical outcomes
August 14, 2018 - Study to examine whether modulating gut bacteria can improve cardiac function in heart failure patients
August 14, 2018 - AI technology could hold key to improving health services
August 14, 2018 - One out of two children not getting enough nutrients needed for their health
August 14, 2018 - Mono-antiplatelet therapy after aortic heart valve replacements may work as well as two drugs
August 14, 2018 - Aid-in-dying patient chooses his last day
August 14, 2018 - Exercise Really Can Chase Away the Blues, to a Point
August 14, 2018 - Surgical mesh implants may cause autoimmune disorders
August 14, 2018 - Researchers develop revolutionary zebrafish model to gain more insight into bone diseases
August 14, 2018 - Researchers discover secret communication hotline between breast cancers and normal cells
August 14, 2018 - Study examines how a person adapts to visual field loss after stroke
August 14, 2018 - Researchers show how specialized nucleic acid-based nanostructures could help target cancer cells
August 14, 2018 - Reducing opioid prescriptions for one operation can also spill over to other procedures
August 14, 2018 - E-cigarettes not so safe but still better than cigarettes
August 14, 2018 - Researchers find link between common ‘harmless’ virus and cardiovascular damage
August 14, 2018 - Initiation of PIMs associated with higher risk of fracture-specific hospitalizations and mortality
August 14, 2018 - Genetically modified mosquitoes and special bed nets help tackle deadly diseases
August 14, 2018 - Advances in treating hep C lead to new option for transplant patients
August 14, 2018 - Study finds quality of doctor-patient discussions about lung cancer screening to be ‘poor’
August 14, 2018 - MSU researchers uncover the effects of aging on regenerative ability of kidneys
August 14, 2018 - Better conditioning, throwing mechanics can help reduce elbow injuries in young baseball pitchers
August 14, 2018 - Brain game doesn’t offer brain gain
August 14, 2018 - Reproductive choices facing women with disabilities require careful consideration
August 14, 2018 - Scientists pinpoint the cause of a rare childhood seizure disorder
August 14, 2018 - Lumpectomy plus radiation associated with reduced risk of breast cancer death, study finds
August 14, 2018 - UAB study shows how ion channel differentiates newborn and mature neurons in the brain
August 14, 2018 - Experts highlight key knowledge gaps that need to be addressed in Ebola vaccine research
August 14, 2018 - Discovery could lead to new drugs against infection and inflammation
August 14, 2018 - Infection Prevention Differs Between Small, Large Hospitals
August 14, 2018 - Mom still matters—In study, young adults tended to prioritize parents over friends
August 14, 2018 - Deep brain stimulation might benefit those with severe alcoholism, preliminary studies show
August 14, 2018 - Study finds increased rate of repeat pregnancies in women with intellectual and developmental disabilities
August 14, 2018 - Lighter sedation fails to reduce risk of postoperative delirium in older patients
August 13, 2018 - Asking better questions about person’s memory could improve doctors’ understanding of patients
August 13, 2018 - U.S. Trauma Doctors Push for Stricter Gun Controls
August 13, 2018 - Asthma and flu: a double whammy
August 13, 2018 - 5 Questions: Donna Zulman on engaging high-need patients in intensive outpatient programs | News Center
August 13, 2018 - Behavioral Nudges Lead to Drop in Prescriptions of Potent Antipsychotic
August 13, 2018 - Potential New Class of Drugs May Reduce Cardiovascular Risk by Targeting Gut Microbes
August 13, 2018 - How to get your kids to eat better
August 13, 2018 - The importance of hearing your patients
August 13, 2018 - Transmission of F. tularensis unlikely to happen through the food chain
August 13, 2018 - Researchers discover epigenetic mechanism underlying ischemic cardiomyopathy
August 13, 2018 - Adolescent health programs receive only a tiny share of international aid, finds research
August 13, 2018 - Fracture risk increases by 30% after gastric bypass, study shows
August 13, 2018 - Quality-improvement project to standardize feeding practices helps micro preemies gain weight
August 13, 2018 - Long-term cannabinoid exposure impairs memory, study shows
High-Dose Aspirin Preferred for Kawasaki’s

High-Dose Aspirin Preferred for Kawasaki’s

image_pdfDownload PDFimage_print

Action Points

  • Note that this observational study leveraged the differing treatment practices at two hospitals to determine that high-dose aspirin may reduce dependence on IVIG for treatment of Kawasaki disease in children.
  • Be aware that this was not a randomized trial; other treatment practices that differ between the two study hospitals may have influenced the results.

The use of low-dose aspirin in conjunction with a single dose of intravenous immunoglobulin (IVIG) among children with Kawasaki disease was associated with three times the risk of requiring a second IVIG dose compared with high-dose aspirin, a retrospective chart review in two Canadian centers concluded.

In one hospital where low-dose acetylsalicylic acid (ASA; 3 to 5 mg/kg/day) was routinely used, 23% of patients were given a second infusion of IVIG, compared with 8.7% of those treated in another hospital where high-dose ASA (80 to 100 mg/kg/day) was used (P=0.003), according to Anita Dhanrajani, MBBS, of British Columbia Children’s Hospital in Vancouver, and colleagues.

In a multivariable analysis that adjusted for potential confounders including platelet count, age, and C-reactive protein (CRP), the odds ratio for a second IVIG dose with low-dose ASA was 3.2 (95% CI 1.1-9.1, P=0.03), the researchers reported online in Arthritis Care & Research.

Kawasaki disease is an acute vasculitis predominantly affecting children younger than age 5 years, and currently is the most common form of acquired heart disease in developed countries, especially among those of Asian ancestry. The disease is associated with potentially severe cardiac outcomes, particularly the development of coronary artery aneurysms.

The American Heart Association (AHA) first published recommendations for diagnosis and treatment of Kawasaki disease in 1993; these have been revised, most recently in 2017. The recommendations, which favor high-dose aspirin, have been developed to assist clinicians in decision-making regarding treatment with IVIG, ASA, and corticosteroids, but have not been uniformly adopted. While an IVIG dosage of 2 g/kg is standard, the aspirin dose has been varied, with high doses possibly having greater anti-inflammatory effects but low doses being assumed to have better gastrointestinal tolerability.

In addition, IVIG can be costly and should be judiciously used, according to Dhanrajani’s group.

The standard approach used at British Columbia Children’s Hospital (center 1) involves a single IVIG infusion plus aspirin, 3 to 5 mg/kg/day, for 6 weeks, while at Stollery Children’s Hospital in Edmonton (center 2), the aspirin dose is 80 to 100 mg/kg/day until 24 to 48 hours after defervescence.

Some 10% to 20% of children with Kawasaki disease fail to respond to the initial IVIG dose, which is referred to as IVIG resistance. These patients usually are given a second dose, but are at increased risk of coronary complications and may have longer hospital stays and adverse events such as hemolytic anemia.

Therefore, to see if IVIG resistance is influenced by ASA dose, the researchers reviewed 122 charts from the years 2009 to 2014 at center 1 and from 127 at center 2 from 2005 to 2014.

At baseline, patient ages ranged from 33 to 36 months, and almost two-thirds were boys. Asians were significantly more common in center 1 (53.3% versus 13.4%, P<0.001).

The brand of IVIG most often used in center 1 was Gamunex, and a local formulation of 10% IVIG was the most common in center 2.

To determine whether the different time frames in the two centers influenced the results, the researchers conducted a secondary analysis that included patients only seen from 2009 to 2014, finding an incidence of IVIG resistance of 23% in center 1 and 7.3% in center 2.

Among patients requiring a second infusion of IVIG, time between infusions ranged from 25 to 66 hours.

In the main multivariate analysis, ethnicity was not included, because it was assigned based on family name, which can be unreliable because of marriage and mixed ethnicity. However, when Asian ethnicity was added to the analysis, 19.5% of Asian children had IVIG resistance compared with 13.8% of non-Asians, which was not a significant difference, and the odds ratio for low-dose ASA and IVIG resistance was 3.7 (95% CI 1.2-11.6, P=0.02).

The mean hospital stay was 4.1 days in center 1 and 4.7 in center 2. “It is surprising that despite the difference in IVIG resistance, we could not document a difference in length of hospital stay between the two centers. This may be due to differences between the centers in usual practices regarding discharge of patients with Kawasaki disease,” the researchers noted.

Coronary artery aneurysms developed in two patients from center 1 and in six patients from center 2, which was not significantly different. The study was not powered to detect a difference in this outcome, however.

The three times increased odds of a second IVIG dose seen with low-dose ASA represented a 14% absolute increase, and the number needed to treat was seven.

“Until there is better evidence from randomized controlled trials, it seems reasonable to adhere to AHA guidelines and prescribe high-dose ASA in the initial phase of Kawasaki disease,” Dhanrajani’s group concluded.

Among the limitations of the study were its retrospective design and a lack of information about adverse events associated with ASA.

Dhanrajani and co-authors disclosed no relevant relationships with industry.

  • Reviewed by
    F. Perry Wilson, MD, MSCE Assistant Professor, Section of Nephrology, Yale School of Medicine and Dorothy Caputo, MA, BSN, RN, Nurse Planner

2018-04-01T00:00:00-0400

last updated

Tagged with:

About author

Related Articles